CLEC2D and myeloid sarcoma: In MS expression profiles, the transcriptional levels of CAMK2G (P = 4.15E-04), CLEC2D (P = 9.11E-04), FOXP1 (P = 2.35E-09), and NUDT14 (P = 1.51E-04) in the GEO data set GSE21942 (Supplementary Table S2) and CAMK2G (P = 3.09E-06), LBH (P = 5.60E-04), SLC2A4RG (P = 1.29E-03), and ZGPAT (P = 6.93E-04) in MS patients were markedly changed compared to controls (Supplementary Table S3).